InsidersTradesSigma
Track the PHARMANUTRA RISULTATI PRIMO SEMESTRE 2023 share price and the full insider trade history of the company, a listed equity based in Italy. Shares are quoted on the IT market, under the oversight of Consob. Operating in the Health Care sector, PHARMANUTRA RISULTATI PRIMO SEMESTRE 2023 has recorded 0 reports. Market capitalisation: €785.2m. The full history is free.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,496 of 29,063 companies
61.9
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.5x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Declarations0 total
No declarations found
0 of 0 declarations
About PHARMANUTRA RISULTATI PRIMO SEMESTRE 2023
PHARMANUTRA reported its results for the first half of 2023, demonstrating strong performance in the health and pharmaceutical sector. The company is listed on the XMIL market.